Senescence Targeting Methods Impact Alzheimer’s Disease Features in 3xTg Mice
Journal of Alzheimer’s Disease · 2024
DOI: 10.3233/jad-230465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Pei Y Ng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Cellular senescence has been associated with neurodegenerative disease and clearance of senescent cells using genetic or pharmaceutical strategies (senolytics) has demonstrated beneficial effects in mouse models investigating individual disease etiologies of Alzheimer’s disease (AD). However, it has remained unclear if senescent cell clearance in a mouse model exhibiting both plaque and tau pathologies modifies the disease state (3xTg).
Objective
To investigate the effects of senescent cell clearance in the 3xTg mouse model.
Methods
3xTg mice were treated with senolytics (ABT263 (navitoclax; NAVI), a combination of dasatinib and quercetin (D+Q)), or subjected to transgene-mediated removal of p16-expressing cells (via INK-ATTAC).
Results
Senolytic treatments consistently reduced microgliosis and ameliorated both amyloid and tau pathology in 3xTg mice. Using RNA sequencing, we found evidence that synaptic dysfunction and neuroinflammation were attenuated with treatment. These beneficial effects were not observed with short-term senolytic treatment in mice with more advanced disease.
Conclusions
Overall, our results further corroborate the beneficial effects senescent cell clearance could have on AD and highlight the importance of early intervention for the treatment of this debilitating disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
- Paul F. Glenn Center for Biology of Aging Research, Mayo Clinic, Rochester, MN, USA.
- The Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
- Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Förderung
- NIA NIH HHS
Zitieren
APA
Ng, P. Y., Zhang, C., Li, H., & Baker, D. J. (2024). Senescence Targeting Methods Impact Alzheimer’s Disease Features in 3xTg Mice. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230465
Vancouver
Ng PY, Zhang C, Li H, Baker DJ. Senescence Targeting Methods Impact Alzheimer’s Disease Features in 3xTg Mice. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-230465
BibTeX
@article{Ng2024,
author = {Ng, Pei Y and Zhang, Cheng and Li, Hu and Baker, Darren J},
title = {Senescence Targeting Methods Impact Alzheimer’s Disease Features in 3xTg Mice},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.3233/jad-230465}
}
EUVIMED